Controlled Substances Act.

WORKING DRAFT

ORIGINAL HOUSE

BILL

NO.
0221

ENROLLED ACT NO. 25, HOUSE OF REPRESENTATIVES

FIFTY-NINTH LEGISLATURE OF THE STATE OF
WYOMING
2007 GENERAL SESSION

AN ACT relating to the Wyoming Controlled Substances Act; adding specified controlled substances to schedules I through V of the
a
ct; moving a controlled substance from schedule V to
s
chedule III of the
a
ct; adding chemical compounds as specified; conforming provisions; and providing for an effective date.

Be It Enacted by the Legislature of the State of
Wyoming
:

Section 1.
W.S. 35
‑
7
‑
1014(d)(xxxi) and by creating new paragraphs (xxxii) through (xxxiv), (f)(vii) and by creating a new paragraph (viii), 35
‑
7
‑
1016(b)(i)(R) and by creating a new subparagraph (S), 35
‑
7
‑
1018(g) and by creating a new subsection (j), 35
‑
7
‑
1020(c)(xlix) and by creating new paragraphs (l) and (li) and 35
‑
7
‑
1022 by creating a new subsection (e) are amended to read:

35
‑
7
‑
1014.

Substances included in Schedule I.

(d)

Hallucinogenic substances
.

‑

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following hallucinogenic substances, their salts, isomers and salts of isomers whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation (for purposes of this paragraph only, the term "isomer" includes the optical, position and geometric isomers):

(xxxi)

1-[1-(2-thienyl)cyclohexyl]pyrrolidine; some other names: TCPy
;
.

(xxxii)

2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7);

(xxxiii)

Alpha-methyltryptamine; (other name: AMT);

(xxxiv)

5-methoxy-N,N-diisopropyltryptamine; (other name: 5-MeO-DIPT).

(f)

Stimulants
.

‑

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers and salts of isomers:

(vii)

N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine)
;
.

(viii)

N-Benzylpiperazine; (some other names: BZP, 1-benzylpiperazine
)
.

35
‑
7
‑
1016.

Substances included in Schedule II.

(b)

Substances, vegetable origin or chemical synthesis
.

‑

Unless specifically excepted or unless listed in another schedule, any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin, independently by means of chemical synthesis or by combination of extraction and chemical synthesis:

(i)

Opium and opiate and any salt, compound, derivative, or preparation of opium or opiate, excluding apomorphine, thebaine-derived butorphanol, dextrorphan, nalbuphine, nalmefene, naloxone and naltrexone and their respective salts, but including the following:

(R)

Thebaine
;
.

(S)

Dihydroetorphine.

35
‑
7
‑
1018.

Substances included in Schedule III.

(g)

Anabolic steroids
.
–
For purposes of this subsection, "anabolic steroid" means any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, corticosteroids and dehydroepiandrosterone) and u
nless specifically excepted or unless listed in another schedule,
include
s

any of the following or any
isomer
ether
, ester, salt or derivative of the following that acts in the same manner on the human body:

(i)

Bodenone;

(ii)

Chlorotestosterone;

(iii)

Clostebol;

(iv)

Dehydrochlormethyltestosterone;

(v)

Dihydrotestosterone;

(vi)

Drostanolone;

(vii)

Ethylestrenol;

(viii)

Fluoxymesterone;

(ix)

Mesterolone;

(x)

Methandienone;

(xi)

Methandranone;

(xii)

Methandriol;

(xiii)

Methandrostenolone;

(xiv)

Methyltestosterone;

(xv)

Mibolerone;

(xvi)

Nandrolone;

(xvii)

Norethandrolone;

(xviii)

Oxandrolone;

(xix)

Oxymesterone;

(xx)

Oxymetholone;

(xxi)

Stanolone;

(xxii)

Stanozolol;

(xxiii)

Testolactone;

(xxiv)

Testosterone; and

(xxv)

Trenbolone;

(xxvi)

Formebulone (formebolone);

(xxvii)

Methenolone;

(xxviii)

Any salt, ester or isomer of a drug or substance described or listed in this paragraph, if that salt, ester or isomer promotes muscle growth, except the term does not include an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the United States secretary of health and humans services for such administration. If any person prescribes, dispenses or distributes such steroid for human use, the person shall be considered to have prescribed, dispensed or distributed an anabolic steroid within the meaning of this paragraph.

(i)

3[beta],17-dihydro-5a-androstane;

(ii)

3[alpha],17[beta]-dihydroxy-5a-androstane;

(iii)

5[alpha]-androstan-3,17-dione;

(iv)

1-androstenediol (3[beta],17[beta]-dihydroxy-5[alpha]-androst-1-ene);

(v)

1-androstenediol (3[alpha],17[beta]-dihydroxy-5[alpha]-androst-1-ene);

(vi)

4-androstenediol (3[beta],17[beta]-dihydroxy-androst-4-ene);

(vii)

5-androstenediol (3[beta],17[beta]-dihydroxy-androst-5-ene);

(viii)

1-androstenedione ([5[alpha]]-androst-1-en-3,17-dione);

(ix)

4-androstenedione (androst-4-en-3,17-dione);

(x)

5-androstenedione (androst-5-en-3,17-dione);

(xi)

Bolasterone (7[alpha],17[alpha]-dimethyl-17[beta]-hydroxyandrost-4-en-3-one);

(xii)

Boldenone (17[beta]-hydroxyandrost-1,4,-diene-3-one)
;

(xiii)

Calusterone (7[beta],17[alpha]-dimethyl-17[beta],hydroxyandrost-4-en-3-one)
;

(xiv)

Clostebol (4chloro-17[beta]-hydroxyandrost-4-en-3-one);

(xv)

Dehydrochloromethyltestosterone (4-chloro-17[beta]-hydroxy-17[alpha]-methyl-androst-1,4dien-3-one)
;

(xvi)

[Delta]1-dihydrotestosterone (also known as
"
1-testosterone
"
) (17[beta]-hydroxy-5[alpha]-androst-1-en-3-one)
;

(xvii)

4-dihydrotestosterone (17[beta]-hydroxy-androstan-3-one);

(xviii)

Drostanolone (17[beta]-hydroxy-2[alpha]-methyl-5[alpha]-androstan-3-one);

(xix)

Ethylestrenol (17[alpha]-ethyl-17[beta]-hydroxyestr-4-ene);

(xx)

Fluoxymesterone (9-fluoro-17[alpha]-methyl-11[beta],17[beta]-dihydroxyandrost-4-en-3-one)
;

(xxi)

Formebolone (2-formyl-17[alpha]-methyl-11[alpha],17[beta]-dihydroxyandrost-1,4-dien-3-one);

(xxii)

Furazabol (17[alpha]-methyl-17[beta]-hydroxyandrostano[2,3-c]-furazan);

(xxiii)

13[beta]-ethyl-17[alpha]-hydroxygon-4-en-3-one);

(xxiv)

4-hydroxytestosterone (4,17[beta]-dihydroxy-androst-4-en-3-one);

(xxv)

4-hydroxy-19-nortestosterone (4,17[beta]-dihydroxy-estr-4-en-3-one);

(xxvi)

Mestanolone (17[alpha]-methyl-17[beta]-hydroxy-5-androstan-3-one);

(xxvii)

Mesterolone (1[alpha]-methyl-17[beta]-hydroxy-[5[alpha]]-androstan-3-one)
;

(xxviii)

Methandienone (17[alpha]-methyl-17[beta]-hydroxyandrost-1,4-dien-3-one)
;

(xxix)

Methandriol (17[alpha]-methyl-3[beta],17[beta]-dihydroxyandrost-5-ene);

(xxx)

Methenolone (1-methyl-17[beta]-hydroxy-5[alpha]-androst-1-en-3-one)
;

(xxxi)

17[alpha]-methyl-3[beta],17[beta]-dihydroxy-5a-androstane)
;

(xxxii)

17[alpha]-methyl-3[alpha],17[beta]-dihydroxy-5a-androstane);

(xxxiii)

17[alpha]-methyl-3[beta],17[beta]-dihydroxyandrost-4-ene);

(xxxiv)

17[alpha]-methyl-4-hydroxynandrolone (17[alpha]-methyl-4-hydroxy-17[beta]-hydroxyestr-4-en-3-one);

(xxxv)

Methyldienolone (17[alpha]-methyl-17[beta]-hydroxyestra-4,9(10)-dien-3-one);

(xxxvi)

Methyltrienolone (17[alpha]-methyl-17[beta]-hydroxyestra-4,9-11-trien-3-one);

(xxxvii)

Methyltestosterone (17[alpha]-methyl-17[beta]-hydroxyandrost-4-en-3-one);

(xxxviii)

Mibolerone (7[alpha],17[alpha]-dimethyl-17[beta]-hydroxyestr-4-en-3-one);

(xxxix)

17[alpha]-methyl-[Delta]1-dihydrotestosterone (17b[beta]-hydroxy-17[alpha]-methyl-5[alpha]-androst-1-en-3-one) (also known as
"
17-[alpha]-methyl-1-tesosterone
"
);

(xl)

Nandrolone (17[beta]-hydroxyestr-4-en-3-
o
ne)
;

(xli)

19-nor-4-androstenediol (3[beta], 17[beta]-dihydroxyestr-4-ene);

(xlii)

19-nor-4-androstenediol (3[alpha], 17[beta]-dihydroxyestr-4-ene);

(xliii)

19-nor-5-androstenediol (3[beta], 17[beta]-dihydroxyestr-5-ene);

(xliv)

19-nor-5-androstenediol (3[alpha], 17[beta]-dihydroxyestr-5-ene);

(xlv)

19-nor-4-androstenedione (estr-4-en-3,17-dione);

(xlvi)

19-nor-5-androstenedione (estr-5-en-3,17-dione);

(xlvii)

Norbolethone (13[beta],17[alpha]-diethyl-17[beta]-hydroxygon-4-en-3-one);

(xlviii)

Norclostebol (4-chloro-17[beta]-hydroxyestr-4-en-3-one);

(xlix)

Norethandrolone (17[alpha]-ethyl-17[beta]-hydroxyestr-4-en-3-one)
;

(l)

Normethandrolone (17[alpha]-methyl-17[beta]-hydroxyestr-4-en-3-one);

(li)

Oxandrolone (17[alpha]-methyl-17[beta]-hydroxy-2-oxa-[5[alpha]]-androstan-3-one)
;

(lii)

Oxymesterone (17[alpha]-methyl-4,17[beta]-dihydroxyandrost-4-en-3-one)
;

(liii)

Oxymetholone (17[alpha]-methyl-2-hydroxymethylene-17[beta]-hydroxy-[5[alpha]]-androstan-3-one)
;

(liv)

Stanozolol (17[alpha]-methyl-17[beta]-hydroxy-[5[alpha]]-androst-2-eno[3,2-c]-pyrazole)
;

(lv)

Stenbolone (17[beta]-hydroxy-2-methyl-[5[alpha]]-androst-1-en-3-one)
;

(lvi)

Testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone);

(lvii)

Testosterone (17[beta]-hydroxyandrost-4-en-3-one);

(lviii)

Tetrahydrogestrinone (13[beta], 17[alpha]-diethyl-17[beta]-hydroxygon-4,9,11-trien-3-one);

(lix)

Trenbolone (17[beta]-hydroestr-4,9,11-trien-3-one);

(lx)

Any salt, ester or ether of a drug or substance described or listed in this subsection, except the term does not include an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the United States secretary of health and humans services for such administration. If any person prescribes, dispenses or distributes such steroid for human use, the person shall be considered to have prescribed, dispensed or distributed an anabolic steroid within the meaning of this subsection
.

(j)

Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation containing any of the following narcotic drugs and their salts, as set forth below:

(i)

Buprenorphine.

35
‑
7
‑
1020.

Substances included in Schedule IV.

(c)

Depressants
.

‑

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts, isomers and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:

(xlix)

Zaleplon
;
.

(l)

Dichloralphenazone;

(li)

Zopiclone.

35
‑
7
‑
1022.

Substances included in Schedule V.

(e)

Any compound, mixture or preparation containing pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid], including its salts, isomers and salts of isomers.

Section 2.
W.S. 35
‑
7
‑
1022(c)(i) is repealed.

Section 3.
This act is effective July 1, 2007.

(END)

Speaker of the House

President of the Senate

Governor

TIME APPROVED: _________

DATE APPROVED: _________

I hereby certify that this act originated in the House.

Chief Clerk

1